Developing a nanoparticle test for prostate cancer scoring View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-12

AUTHORS

Qun Huo, Sally A Litherland, Shannon Sullivan, Hillari Hallquist, David A Decker, Inoel Rivera-Ramirez

ABSTRACT

BACKGROUND: Over-diagnosis and treatment of prostate cancer has been a major problem in prostate cancer care and management. Currently the most relevant prognostic factor to predict a patient's risk of death due to prostate cancer is the Gleason score of the biopsied tissue samples. However, pathological analysis is subjective, and the Gleason score is only a qualitative estimate of the cancer malignancy. Molecular biomarkers and diagnostic tests that can accurately predict prostate tumor aggressiveness are rather limited. METHOD: We report here for the first time the development of a nanoparticle test that not only can distinguish prostate cancer from normal and benign conditions, but also has the potential to predict the aggressiveness of prostate cancer quantitatively. To conduct the test, a prostate tissue lysate sample is spiked into a blood serum or human IgG solution and the spiked sample is incubated with a citrate-protected gold nanoparticle solution. IgG is known to adsorb to citrate-protected gold nanoparticles to form a "protein corona" on the nanoparticle surface. From this study, we discovered that certain tumor-specific molecules can interact with IgG and change the adsorption behavior of IgG to the gold nanoparticles. This change is reflected in the nanoparticle size of the assay solution and detected by a dynamic light scattering technique. Assay data were analyzed by one-way ANOVA for multiple variant analysis, and using the Student t-test or nonparametric Mann-Whitney U-tests for pairwise analyses. RESULTS: An inverse, quantitative correlation of the average nanoparticle size of the assay solution with tumor status and histological diagnostic grading was observed from the nanoparticle test. IgG solutions spiked with prostate tumor tissue exhibit significantly smaller nanoparticle size than the solutions spiked with normal and benign tissues. The higher grade the tumor is, the smaller the nanoparticle size is. The test particularly revealed large differences among the intermediate Grade 2 tumors, and suggested the need to treat them differently. CONCLUSION: Development of a new nanoparticle test may provide a quantitative measure of the prostate cancer aggressiveness. If validated in a larger study of patients with prostate cancer, this test could become a new diagnostic tool in conjunction with Gleason Score pathology diagnostics to better distinguish aggressive cancer from indolent tumor. More... »

PAGES

44

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1479-5876-10-44

DOI

http://dx.doi.org/10.1186/1479-5876-10-44

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001195837

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22404986


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adsorption", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gold", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin G", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metal Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Biological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanotechnology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Solutions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Extracts", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Central Florida", 
          "id": "https://www.grid.ac/institutes/grid.170430.1", 
          "name": [
            "NanoScience Technology Center and Department of Chemistry, University of Central Florida, 12424 Research Parkway Suite 400, 32826, Orlando, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huo", 
        "givenName": "Qun", 
        "id": "sg:person.01124223262.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124223262.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Florida Hospital Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.414938.3", 
          "name": [
            "Florida Hospital Cancer Institute, 2501 North Orange Ave Suite 247, 32804, Orlando, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Litherland", 
        "givenName": "Sally A", 
        "id": "sg:person.0756256454.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756256454.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Central Florida", 
          "id": "https://www.grid.ac/institutes/grid.170430.1", 
          "name": [
            "NanoScience Technology Center and Department of Chemistry, University of Central Florida, 12424 Research Parkway Suite 400, 32826, Orlando, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sullivan", 
        "givenName": "Shannon", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Central Florida", 
          "id": "https://www.grid.ac/institutes/grid.170430.1", 
          "name": [
            "NanoScience Technology Center and Department of Chemistry, University of Central Florida, 12424 Research Parkway Suite 400, 32826, Orlando, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hallquist", 
        "givenName": "Hillari", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Florida Hospital Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.414938.3", 
          "name": [
            "Florida Hospital Cancer Institute, 2501 North Orange Ave Suite 247, 32804, Orlando, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Decker", 
        "givenName": "David A", 
        "id": "sg:person.0627706630.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627706630.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Florida Hospital Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.414938.3", 
          "name": [
            "Florida Hospital Cancer Institute, 2501 North Orange Ave Suite 247, 32804, Orlando, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rivera-Ramirez", 
        "givenName": "Inoel", 
        "id": "sg:person.0577356353.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577356353.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/35074122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001419011", 
          "https://doi.org/10.1038/35074122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35074122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001419011", 
          "https://doi.org/10.1038/35074122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1148/radiol.2523081423", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009757101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2006.06.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018624787"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.colsurfb.2010.03.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018972302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14712598.8.10.1461", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023911833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0019605", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029395313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0019605", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029395313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nano.2008.08.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030149218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-3155-9-20", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030929231", 
          "https://doi.org/10.1186/1477-3155-9-20"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djp001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031887748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ab.2010.06.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038536154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0805135105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047169265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/ac901822w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055071708"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/ac901822w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055071708"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/ja711298b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055857625"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/ja711298b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055857625"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/nl101746v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056218044"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/nl101746v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056218044"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076602135", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-12", 
    "datePublishedReg": "2012-12-01", 
    "description": "BACKGROUND: Over-diagnosis and treatment of prostate cancer has been a major problem in prostate cancer care and management. Currently the most relevant prognostic factor to predict a patient's risk of death due to prostate cancer is the Gleason score of the biopsied tissue samples. However, pathological analysis is subjective, and the Gleason score is only a qualitative estimate of the cancer malignancy. Molecular biomarkers and diagnostic tests that can accurately predict prostate tumor aggressiveness are rather limited.\nMETHOD: We report here for the first time the development of a nanoparticle test that not only can distinguish prostate cancer from normal and benign conditions, but also has the potential to predict the aggressiveness of prostate cancer quantitatively. To conduct the test, a prostate tissue lysate sample is spiked into a blood serum or human IgG solution and the spiked sample is incubated with a citrate-protected gold nanoparticle solution. IgG is known to adsorb to citrate-protected gold nanoparticles to form a \"protein corona\" on the nanoparticle surface. From this study, we discovered that certain tumor-specific molecules can interact with IgG and change the adsorption behavior of IgG to the gold nanoparticles. This change is reflected in the nanoparticle size of the assay solution and detected by a dynamic light scattering technique. Assay data were analyzed by one-way ANOVA for multiple variant analysis, and using the Student t-test or nonparametric Mann-Whitney U-tests for pairwise analyses.\nRESULTS: An inverse, quantitative correlation of the average nanoparticle size of the assay solution with tumor status and histological diagnostic grading was observed from the nanoparticle test. IgG solutions spiked with prostate tumor tissue exhibit significantly smaller nanoparticle size than the solutions spiked with normal and benign tissues. The higher grade the tumor is, the smaller the nanoparticle size is. The test particularly revealed large differences among the intermediate Grade 2 tumors, and suggested the need to treat them differently.\nCONCLUSION: Development of a new nanoparticle test may provide a quantitative measure of the prostate cancer aggressiveness. If validated in a larger study of patients with prostate cancer, this test could become a new diagnostic tool in conjunction with Gleason Score pathology diagnostics to better distinguish aggressive cancer from indolent tumor.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1479-5876-10-44", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032886", 
        "issn": [
          "1479-5876"
        ], 
        "name": "Journal of Translational Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "Developing a nanoparticle test for prostate cancer scoring", 
    "pagination": "44", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "05b27cd901f5c90e333a13f11ab03b75ae2a8a3c0aa1f512f36a8170656043ee"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22404986"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101190741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1479-5876-10-44"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001195837"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1479-5876-10-44", 
      "https://app.dimensions.ai/details/publication/pub.1001195837"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000509.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1479-5876-10-44"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-10-44'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-10-44'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-10-44'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-10-44'


 

This table displays all metadata directly associated to this object as RDF triples.

202 TRIPLES      21 PREDICATES      57 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1479-5876-10-44 schema:about N1c2aa9db20694bf190eb023f5bd70777
2 N246c41f30a7b49b19f88a5e77d5572ea
3 N718f4d0b360045ecb66cc3c698b116e8
4 N71bfe092931b470faf1f64f092ad895c
5 N8753995f9d114c9cb29c02ac666887f4
6 N8ae6f0849a5c488db1aa4010ca84dbbb
7 N96c091429b3040c69738266963852162
8 N9c6d892127104b3e9dead6a1f1e990db
9 Na61586c8f0ae42929ebfe987378fb74c
10 Nc2a7497dfb344c5b83efc51789cb975f
11 Neef78a4060494b4698f66a00605457be
12 Nf1481a8401244658bfd8586949ff3599
13 Nffa3ff44f2c34a4ea8b8e8afb63ad03f
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author N6881300430ab44ee8926bb3acad938f1
17 schema:citation sg:pub.10.1038/35074122
18 sg:pub.10.1186/1477-3155-9-20
19 https://app.dimensions.ai/details/publication/pub.1076602135
20 https://doi.org/10.1016/j.ab.2010.06.008
21 https://doi.org/10.1016/j.colsurfb.2010.03.012
22 https://doi.org/10.1016/j.eururo.2006.06.009
23 https://doi.org/10.1016/j.nano.2008.08.001
24 https://doi.org/10.1021/ac901822w
25 https://doi.org/10.1021/ja711298b
26 https://doi.org/10.1021/nl101746v
27 https://doi.org/10.1073/pnas.0805135105
28 https://doi.org/10.1093/jnci/djp001
29 https://doi.org/10.1148/radiol.2523081423
30 https://doi.org/10.1371/journal.pone.0019605
31 https://doi.org/10.1517/14712598.8.10.1461
32 schema:datePublished 2012-12
33 schema:datePublishedReg 2012-12-01
34 schema:description BACKGROUND: Over-diagnosis and treatment of prostate cancer has been a major problem in prostate cancer care and management. Currently the most relevant prognostic factor to predict a patient's risk of death due to prostate cancer is the Gleason score of the biopsied tissue samples. However, pathological analysis is subjective, and the Gleason score is only a qualitative estimate of the cancer malignancy. Molecular biomarkers and diagnostic tests that can accurately predict prostate tumor aggressiveness are rather limited. METHOD: We report here for the first time the development of a nanoparticle test that not only can distinguish prostate cancer from normal and benign conditions, but also has the potential to predict the aggressiveness of prostate cancer quantitatively. To conduct the test, a prostate tissue lysate sample is spiked into a blood serum or human IgG solution and the spiked sample is incubated with a citrate-protected gold nanoparticle solution. IgG is known to adsorb to citrate-protected gold nanoparticles to form a "protein corona" on the nanoparticle surface. From this study, we discovered that certain tumor-specific molecules can interact with IgG and change the adsorption behavior of IgG to the gold nanoparticles. This change is reflected in the nanoparticle size of the assay solution and detected by a dynamic light scattering technique. Assay data were analyzed by one-way ANOVA for multiple variant analysis, and using the Student t-test or nonparametric Mann-Whitney U-tests for pairwise analyses. RESULTS: An inverse, quantitative correlation of the average nanoparticle size of the assay solution with tumor status and histological diagnostic grading was observed from the nanoparticle test. IgG solutions spiked with prostate tumor tissue exhibit significantly smaller nanoparticle size than the solutions spiked with normal and benign tissues. The higher grade the tumor is, the smaller the nanoparticle size is. The test particularly revealed large differences among the intermediate Grade 2 tumors, and suggested the need to treat them differently. CONCLUSION: Development of a new nanoparticle test may provide a quantitative measure of the prostate cancer aggressiveness. If validated in a larger study of patients with prostate cancer, this test could become a new diagnostic tool in conjunction with Gleason Score pathology diagnostics to better distinguish aggressive cancer from indolent tumor.
35 schema:genre research_article
36 schema:inLanguage en
37 schema:isAccessibleForFree true
38 schema:isPartOf Naf340df2ad984ca4981fec30f6af3e11
39 Nd563fc3b61b7480984688a8dea53018e
40 sg:journal.1032886
41 schema:name Developing a nanoparticle test for prostate cancer scoring
42 schema:pagination 44
43 schema:productId N32791c7029de483b9e7aa647547ed3d9
44 N63426b4dd0bf42a58b52eff472656a58
45 Nba83e3755f3643d39a4b7d8dc2ec9ceb
46 Nde5fd218307047d998f2b15022a13fc1
47 Ne6b952896bc447a39f49b8e3302e5d5a
48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001195837
49 https://doi.org/10.1186/1479-5876-10-44
50 schema:sdDatePublished 2019-04-10T15:50
51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
52 schema:sdPublisher N262fac0bbd8b495d9029887c1d871c9b
53 schema:url http://link.springer.com/10.1186%2F1479-5876-10-44
54 sgo:license sg:explorer/license/
55 sgo:sdDataset articles
56 rdf:type schema:ScholarlyArticle
57 N0b1ef185197c4a2a90e6cf3ba6a748ed rdf:first sg:person.0756256454.89
58 rdf:rest Nea67c70edf42463bb7011fdb88685c7d
59 N1c2aa9db20694bf190eb023f5bd70777 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Models, Biological
61 rdf:type schema:DefinedTerm
62 N246c41f30a7b49b19f88a5e77d5572ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Solutions
64 rdf:type schema:DefinedTerm
65 N262fac0bbd8b495d9029887c1d871c9b schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N32791c7029de483b9e7aa647547ed3d9 schema:name pubmed_id
68 schema:value 22404986
69 rdf:type schema:PropertyValue
70 N63426b4dd0bf42a58b52eff472656a58 schema:name readcube_id
71 schema:value 05b27cd901f5c90e333a13f11ab03b75ae2a8a3c0aa1f512f36a8170656043ee
72 rdf:type schema:PropertyValue
73 N6881300430ab44ee8926bb3acad938f1 rdf:first sg:person.01124223262.98
74 rdf:rest N0b1ef185197c4a2a90e6cf3ba6a748ed
75 N718f4d0b360045ecb66cc3c698b116e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Prostatic Neoplasms
77 rdf:type schema:DefinedTerm
78 N71bfe092931b470faf1f64f092ad895c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Immunoglobulin G
80 rdf:type schema:DefinedTerm
81 N73402fb0085b4a8781bf853bfee7cf88 schema:affiliation https://www.grid.ac/institutes/grid.170430.1
82 schema:familyName Sullivan
83 schema:givenName Shannon
84 rdf:type schema:Person
85 N8753995f9d114c9cb29c02ac666887f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Gold
87 rdf:type schema:DefinedTerm
88 N8ae6f0849a5c488db1aa4010ca84dbbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Neoplasm Proteins
90 rdf:type schema:DefinedTerm
91 N903e0adb064d47ca97d29e93d08af5bb rdf:first sg:person.0577356353.06
92 rdf:rest rdf:nil
93 N96c091429b3040c69738266963852162 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Humans
95 rdf:type schema:DefinedTerm
96 N9c6d892127104b3e9dead6a1f1e990db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Tissue Extracts
98 rdf:type schema:DefinedTerm
99 Na61586c8f0ae42929ebfe987378fb74c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Male
101 rdf:type schema:DefinedTerm
102 Naf340df2ad984ca4981fec30f6af3e11 schema:volumeNumber 10
103 rdf:type schema:PublicationVolume
104 Nb3cb0134ab21474e98195bc55d49f300 schema:affiliation https://www.grid.ac/institutes/grid.170430.1
105 schema:familyName Hallquist
106 schema:givenName Hillari
107 rdf:type schema:Person
108 Nb9841bbfba2d4148ab87aefd08659fd4 rdf:first sg:person.0627706630.45
109 rdf:rest N903e0adb064d47ca97d29e93d08af5bb
110 Nba83e3755f3643d39a4b7d8dc2ec9ceb schema:name nlm_unique_id
111 schema:value 101190741
112 rdf:type schema:PropertyValue
113 Nc2a7497dfb344c5b83efc51789cb975f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Metal Nanoparticles
115 rdf:type schema:DefinedTerm
116 Nd563fc3b61b7480984688a8dea53018e schema:issueNumber 1
117 rdf:type schema:PublicationIssue
118 Ndb30939e6afa40bead21f987761d3e49 rdf:first Nb3cb0134ab21474e98195bc55d49f300
119 rdf:rest Nb9841bbfba2d4148ab87aefd08659fd4
120 Nde5fd218307047d998f2b15022a13fc1 schema:name doi
121 schema:value 10.1186/1479-5876-10-44
122 rdf:type schema:PropertyValue
123 Ne6b952896bc447a39f49b8e3302e5d5a schema:name dimensions_id
124 schema:value pub.1001195837
125 rdf:type schema:PropertyValue
126 Nea67c70edf42463bb7011fdb88685c7d rdf:first N73402fb0085b4a8781bf853bfee7cf88
127 rdf:rest Ndb30939e6afa40bead21f987761d3e49
128 Neef78a4060494b4698f66a00605457be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Nanotechnology
130 rdf:type schema:DefinedTerm
131 Nf1481a8401244658bfd8586949ff3599 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Serum
133 rdf:type schema:DefinedTerm
134 Nffa3ff44f2c34a4ea8b8e8afb63ad03f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Adsorption
136 rdf:type schema:DefinedTerm
137 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
138 schema:name Medical and Health Sciences
139 rdf:type schema:DefinedTerm
140 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
141 schema:name Oncology and Carcinogenesis
142 rdf:type schema:DefinedTerm
143 sg:journal.1032886 schema:issn 1479-5876
144 schema:name Journal of Translational Medicine
145 rdf:type schema:Periodical
146 sg:person.01124223262.98 schema:affiliation https://www.grid.ac/institutes/grid.170430.1
147 schema:familyName Huo
148 schema:givenName Qun
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124223262.98
150 rdf:type schema:Person
151 sg:person.0577356353.06 schema:affiliation https://www.grid.ac/institutes/grid.414938.3
152 schema:familyName Rivera-Ramirez
153 schema:givenName Inoel
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577356353.06
155 rdf:type schema:Person
156 sg:person.0627706630.45 schema:affiliation https://www.grid.ac/institutes/grid.414938.3
157 schema:familyName Decker
158 schema:givenName David A
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627706630.45
160 rdf:type schema:Person
161 sg:person.0756256454.89 schema:affiliation https://www.grid.ac/institutes/grid.414938.3
162 schema:familyName Litherland
163 schema:givenName Sally A
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756256454.89
165 rdf:type schema:Person
166 sg:pub.10.1038/35074122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001419011
167 https://doi.org/10.1038/35074122
168 rdf:type schema:CreativeWork
169 sg:pub.10.1186/1477-3155-9-20 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030929231
170 https://doi.org/10.1186/1477-3155-9-20
171 rdf:type schema:CreativeWork
172 https://app.dimensions.ai/details/publication/pub.1076602135 schema:CreativeWork
173 https://doi.org/10.1016/j.ab.2010.06.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038536154
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1016/j.colsurfb.2010.03.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018972302
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1016/j.eururo.2006.06.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018624787
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/j.nano.2008.08.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030149218
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1021/ac901822w schema:sameAs https://app.dimensions.ai/details/publication/pub.1055071708
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1021/ja711298b schema:sameAs https://app.dimensions.ai/details/publication/pub.1055857625
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1021/nl101746v schema:sameAs https://app.dimensions.ai/details/publication/pub.1056218044
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1073/pnas.0805135105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047169265
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1093/jnci/djp001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031887748
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1148/radiol.2523081423 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009757101
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1371/journal.pone.0019605 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029395313
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1517/14712598.8.10.1461 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023911833
196 rdf:type schema:CreativeWork
197 https://www.grid.ac/institutes/grid.170430.1 schema:alternateName University of Central Florida
198 schema:name NanoScience Technology Center and Department of Chemistry, University of Central Florida, 12424 Research Parkway Suite 400, 32826, Orlando, FL, USA
199 rdf:type schema:Organization
200 https://www.grid.ac/institutes/grid.414938.3 schema:alternateName Florida Hospital Cancer Institute
201 schema:name Florida Hospital Cancer Institute, 2501 North Orange Ave Suite 247, 32804, Orlando, FL, USA
202 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...